Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon. This occurred while President Trump was announcing a plan to lower the cost of weight-loss medications, including Ozempic.
Findlay was assisted promptly, received medical attention, and is expected to recover fully.
The incident was captured on camera during the announcement. President Trump's plan focuses on making weight-loss drugs more affordable.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
Web Editor: Jodi Leese Glusco
Posted: November 6, 2025
"Findlay was helped to his feet, given medical assistance and is expected to be fine."
Author's Summary: Novo Nordisk executive Gordon Findlay fainted during President Trump's announcement to lower weight-loss drug prices, but he was promptly treated and is expected to recover.